Drug Pipeline Progress: Positive clinical trial results for NVGT's drug candidates often lead to price increases. Conversely, setbacks or failures can cause significant drops.

Regulatory Approvals: FDA approval of NVGT's drugs is a major catalyst for stock appreciation. Delays or rejections negatively impact the price.

Market Sentiment: Overall investor confidence in the biotechnology sector and the broader market influences NVGT's stock price. Negative sentiment can pressure the stock.

Competition: The emergence of competing drugs or therapies from other companies can decrease the potential market share for NVGT's products, affecting its valuation.

Financial Performance: NVGT's revenue, earnings, and cash flow influence investor perception and the stock price. Strong financial results generally lead to price gains.

Partnerships and Acquisitions: Strategic collaborations or acquisitions can boost investor confidence and the stock price. Terminated agreements may have the opposite effect.

Intellectual Property: The strength and scope of NVGT's patent portfolio are crucial. Legal challenges to its patents can negatively impact investor sentiment and the stock price.